Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -81.10 | 26.97 |
| PEG Ratio (TTM) | 0.42 | 2.71 |
| P/S Ratio (TTM) | 1.01 | 2.61 |
| P/B Ratio (TTM) | 2.64 | 8.91 |
| P/FCF Ratio (TTM) | 20.74 | 23.50 |
| Price to 5YR AVG Earnings Ratio | 107.17 | 37.27 |
| Price to 5YR AVG FCF Ratio | 105.16 | 38.76 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.32% | 15.20% |
| ROE (TTM) | -3.21% | 32.76% |
| Net Profit Margin (TTM) | -1.25% | 8.76% |
| ROIC 5YR AVG | 5.83% | 30.98% |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -221.93% | 8.15% | -43.72% |
| Revenue | 4.19% | 6.56% | 46.34% |
| Net Income | -222.25% | 29.25% | -30.92% |
| Cash Flow | 87.47% | 38.59% | 168.16% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.50 | 2.75 |
| Quick Ratio (TTM) | 1.28 | 1.48 |
| D/E Ratio (TTM) | 0.95 | 0.55 |
| Interest Coverage (TTM) | 2.87 | 43.28 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | 2.41 | 11.31 |
| LTL to 5YR AVG FCF | 32.78 | 2.86 |
| Shares Outstanding Growth 5YR AVG | 40.92% | -0.71% |